Insulin glargine and lixisenatide Subcutaneous and Raltegravir Powder for Oral Suspension
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Raltegravir Powder for Oral Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: raltegravir
Brand name: Isentress, Isentress HD
Synonyms: Raltegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Raltegravir Tablets
- Insulin glargine and lixisenatide Subcutaneous-Ramelteon
- Insulin glargine and lixisenatide Subcutaneous-Ramelteon Tablets
- Insulin glargine and lixisenatide Subcutaneous-Ramipril
- Insulin glargine and lixisenatide Subcutaneous-Ramipril Tablets
- Insulin glargine and lixisenatide Subcutaneous-Ramucirumab
- Raltegravir Powder for Oral Suspension-Insulin glargine, recombinant Subcutaneous
- Raltegravir Powder for Oral Suspension-Insulin glulisine
- Raltegravir Powder for Oral Suspension-Insulin Glulisine (Cartridges and Pens)
- Raltegravir Powder for Oral Suspension-Insulin Glulisine (Vials)
- Raltegravir Powder for Oral Suspension-Insulin glulisine Subcutaneous
- Raltegravir Powder for Oral Suspension-Insulin human inhaled Inhalation